公开(公告)号：US20130134525A1

公开(公告)日：2013-05-30

申请号：US13807315

申请日：2011-11-30

Applicant: Yan Jin

Inventor： Yan Jin

IPC: H01L29/66 ,  H01L29/78

CPC classification number: H01L29/66477 ,  H01L29/42368 ,  H01L29/78 ,  H01L29/7836

Abstract: A Metal-Oxide-Semiconductor (MOS) device is disclosed. The MOS device includes a substrate, a well region formed in the substrate, and a gate located on the substrate. The MOS device also includes a first lightly-doped region arranged in the well region at a first side of the gate and overlapping with the gate, and a second lightly-doped region arranged in the well region at a second side of the gate and overlapping with the gate. Further, the MOS device includes a first heavily-doped region formed in the first lightly-doped region, and a second heavily-doped region formed in the second lightly-doped region. The MOS device also includes a first high-low-voltage gate oxide boundary arranged between the first heavily-doped region and the gate, and a second high-low-voltage gate oxide boundary arranged between the second heavily-doped region and the gate. The gate covers the first high-low-voltage gate oxide boundary and the second high-low-voltage gate oxide boundary at the first side and the second side of the gate, respectively.

Abstract translation: 公开了一种金属氧化物半导体（MOS）器件。 MOS器件包括衬底，形成在衬底中的阱区和位于衬底上的栅极。 MOS器件还包括布置在栅极的第一侧的阱区中并与栅极重叠的第一轻掺杂区域和布置在栅极第二侧的阱区中的第二轻掺杂区域，并且重叠 与门。 此外，MOS器件包括形成在第一轻掺杂区域中的第一重掺杂区域和形成在第二轻掺杂区域中的第二重掺杂区域。 MOS器件还包括布置在第一重掺杂区域和栅极之间的第一高低电压栅极氧化物边界和布置在第二重掺杂区域和栅极之间的第二高低压栅极氧化物边界。 栅极分别在栅极的第一侧和第二侧覆盖第一高低压栅极氧化物边界和第二高低压栅极氧化物边界。

公开(公告)号：US07483841B1

公开(公告)日：2009-01-27

申请号：US09906947

申请日：2001-07-13

Applicant: Yan Jin ,  John Kunz ,  Raymond Levitt ,  Marc Ramsey ,  Carlos Rivero ,  Charles Thaeler

Inventor： Yan Jin ,  John Kunz ,  Raymond Levitt ,  Marc Ramsey ,  Carlos Rivero ,  Charles Thaeler

IPC: G06F17/60

CPC classification number: G06Q10/06 ,  G06Q10/063 ,  G06Q10/0631 ,  G06Q10/063118

Abstract: A program management structure that includes a plurality of projects, where each project is staffed with a project manager and wherein each project includes a plurality of tasks which can have multiple interdependencies and at least one position reporting up to the project manager. A plurality of organizations is also included, where each organization is provided with a plurality of departments, each of which has a department manager and at least one staffer reporting up to the department manager and filling at least part of the at least one position. Additionally, project exceptions are reported to the project manager and functional exceptions are reported to the functional manager.

Abstract translation: 一种程序管理结构，其包括多个项目，其中每个项目都配备有项目经理，并且其中每个项目包括可以具有多个相互依赖性的多个任务和至少一个位置报告给项目经理。 还包括多个组织，每个组织都设有多个部门，每个部门都有一个部门经理，至少有一名员工向部门经理报告，并填写至少一部分至少一个职位。 此外，项目例外情况向项目经理报告，功能异常报告给职能经理。

公开(公告)号：US20080312429A1

公开(公告)日：2008-12-18

申请号：US12095797

申请日：2006-12-01

Applicant: Peixue Ling ,  Yanli He ,  Jianying Chen ,  Jie Liu ,  Tianmin Zhang ,  Xueping Guo ,  Yan Jin

Inventor： Peixue Ling ,  Yanli He ,  Jianying Chen ,  Jie Liu ,  Tianmin Zhang ,  Xueping Guo ,  Yan Jin

IPC: C08B37/08 ,  C07H23/00

CPC classification number: A61K31/728 ,  C08B37/0072

Abstract: The present invention discloses a bismuth hyaluronate, characterized in that the bismuth content is from 0.5% to 40%, and the glucuronate content is from 20% to 45%, based on dry weight. Also provided is a method for the preparation of said bismuth hyaluronate comprising reaction of a soluble hyaluronate salt with a bismuth salt in a basic aqueous solution, followed by steps of precipitation, filtration, desalting, dehydrating and drying to obtain the product. Further disclosed is the use of the bismuth hyaluronate in the manufacture of a medicament or health foods for preventing and treating gastrointestinal disorders, in particular ulcerous disorders of the GI tract. It has been proven in animal experiments to show a better therapeutic effect than products of the same type.

Abstract translation: 本发明公开了一种透明质酸铋，其特征在于，所述铋含量为0.5〜40％，所述葡萄糖醛酸酯含量为20〜45％。 还提供了一种制备所述透明质酸铋的方法，包括在碱性水溶液中使可溶性透明质酸盐与铋盐反应，然后进行沉淀，过滤，脱盐，脱水和干燥以获得产物。 进一步披露的是透明质酸铋在制造用于预防和治疗胃肠道疾病，特别是胃肠道溃疡性疾病的药物或保健食品中的用途。 在动物实验中已经证明比相同类型的产品显示更好的治疗效果。

公开(公告)号：US20080263729A1

公开(公告)日：2008-10-23

申请号：US11662360

申请日：2005-09-08

Applicant: Eviatar Nevo ,  Yan Jin ,  Weining Song

Inventor： Eviatar Nevo ,  Yan Jin ,  Weining Song

IPC: A01H5/00 ,  C07H21/04 ,  C12N15/63 ,  C12N1/21 ,  C12N1/19 ,  C12N5/10

CPC classification number: C12N9/1205

Abstract: The present invention provides a MAP kinase homologue gene, designated EhHOG, isolated from Eurotium herbariorum, a common fungal species from the extreme hypersaline environment of the Dead Sea, capable of improving tolerance of plants and other organisms to abiotic stresses such as osmotic, heat, dehydration, freezing-thawing, oxidative and salinity stress.

Abstract translation: 本发明提供了一种命名为EhHOG的MAP激酶同源基因，其从来自死海的极端高盐环境的常见真菌物种Eurotium herbariorum分离，能够改善植物和其他生物体对非生物胁迫如渗透， 脱水，冻融，氧化和盐分胁迫。

公开(公告)号：US20080188422A1

公开(公告)日：2008-08-07

申请号：US11569919

申请日：2005-06-01

Applicant: James A. Cowan ,  Yan Jin ,  Seth Bradford ,  Nikhil Gokhale ,  Ada Cowan ,  Chun-An Chen

Inventor： James A. Cowan ,  Yan Jin ,  Seth Bradford ,  Nikhil Gokhale ,  Ada Cowan ,  Chun-An Chen

IPC: A61K38/00 ,  C07K14/00 ,  C07D257/00 ,  A61P9/00 ,  A61P3/10 ,  A61P37/00 ,  C07K7/00

CPC classification number: A61K47/64

Abstract: Ligands having a metal binding domain and a targeting domain are provided. The ligands can be used to target, inhibit, and catalytically degrade or inactivate a desired target. Methods of treating a disease or condition using the ligands are also provided.

Abstract translation: 提供了具有金属结合结构域和靶向结构域的配体。 配体可用于靶向，抑制和催化降解或灭活所需靶。 还提供了使用配体治疗疾病或病症的方法。